Straight answers,
before you commit.

No. Membership covers clinical time, monitoring, and access, and is paid directly. Many labs and conventional medical services can still be billed to your insurance — we tell you which before anything is ordered, and we never order first and explain later.

Laboratory panels, imaging, and any prescribed medication or compounded therapy are billed separately. Members receive our negotiated pricing, itemized, with no markup on labs.

Yes. You can move between tiers at any interval, and cancel with 30 days' notice. Records and lab history remain yours and are released on request.

It is capacity-limited rather than exclusive for its own sake — direct clinician access only works if the number of patients holding it stays small. Enquire and we'll tell you honestly whether there is room.

A long intake: history, goals, lifestyle, medications, and a comprehensive panel drawn before or at the visit. You leave with a written plan only after the results are back and reviewed with you — not on day one.

No. Vivier can act as your primary care or work alongside it. We share records and coordinate with your specialists rather than duplicating their work.

Our clinicians and physician lead every care plan personally, supported by advanced practice clinicians for follow-up, monitoring, and between-visit questions.

It depends on tier and protocol, but the principle is fixed: anything we start gets re-measured on a defined schedule, and anything that isn't working gets stopped.

Some are. The GLP-1 medications (semaglutide, tirzepatide, liraglutide), tesamorelin, and bremelanotide have FDA approvals for specific indications. Many other peptides are compounded or investigational and are not FDA-approved for the uses commonly discussed online. We say which is which, every time.

Because sourcing, evidence, and risk vary enormously between agents. Some are appropriate for a narrow group of patients; some we decline entirely. If we say no, you'll get the reasoning, not a brush-off.

From licensed compounding pharmacies with documented testing. We do not sell product from the office, and we do not use research-grade material.

No — and any clinic implying otherwise is selling something. Therapies are layered on top of the fundamentals, and we measure whether they add anything.

When peptide therapy is clinically appropriate and prescribed, medications are sourced through appropriately licensed U.S.-based compounding pharmacies operating under applicable Section 503A requirements or FDA-registered 503B outsourcing facilities, depending on the medication and clinical circumstances.

We carefully evaluate our pharmacy partners and prioritize transparent sourcing, quality-control practices, and appropriate testing and documentation. We do not obtain medications from unverified peptide websites, overseas suppliers, or vendors selling products labeled “for research use only.”

Every treatment plan begins with a clinical evaluation and includes individualized prescribing, dosing, education, and ongoing monitoring. Compounded medications are not FDA-approved and are prescribed only when considered appropriate for the individual patient.

19–21 Fair Lawn Ave, Fair Lawn, NJ 07410, serving Bergen County and Northern New Jersey. Parking is on site.

Yes, for follow-up and reviews where clinically appropriate. Initial evaluation and lab draws happen in person.

Yes. Members get a single place to see labs, current protocol, and the date of their next review, accessible from your phone.

This fall. Waitlist members are contacted first, in the order they joined, with availability and full pricing detail.